Gene · 51547
Papers2,721
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,721
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SIRT7-Mediated MVP Desuccinylation Facilitates Tongue Squamous Cell Carcinoma Progression by Activating JAK2/STAT3 Pathway. | Cell Biol Int | 2025 | 40586636 | PubTator, text mining | PubMed |
| A comprehensive review of histone modifications during mammalian oogenesis and early embryo development. | Histochem Cell Biol | 2025 | 40580240 | PubTator, text mining | PubMed |
| Correction to: SIRT7 antagonizes human stem cell aging as a heterochromatin stabilizer. | Protein Cell | 2025 | 40391739 | PubTator, text mining | PubMed |
| GTF3C2 Promotes the Proliferation of Hepatocellular Carcinoma Cells through the USP21/MEK2/ERK1/2 Pathway. | J Clin Transl Hepatol | 2025 | 40385937 | PubTator, text mining | PubMed |
| Exploring the Relationship of Transposable Elements and Ageing: Causes and Consequences. | Genome Biol Evol | 2025 | 40373205 | PubTator, text mining | PubMed |
| The tongue coating microbiome is perturbed in atrial fibrillation and partly normalized after catheter ablation. | Front Microbiol | 2025 | 40371119 | PubTator, text mining | PubMed |
| Competitive binding between DDX21 and SIRT7 enhances NAT10-mediated ac4C modification to promote colorectal cancer metastasis and angiogenesis- DDX21 promotes colorectal cancer metastasis. | Cell Death Dis | 2025 | 40301349 | PubTator, text mining | PubMed |
| Small extracellular vesicles: the origins, current status, future prospects, and applications. | Stem Cell Res Ther | 2025 | 40247402 | PubTator, text mining | PubMed |
| SIRT7 Is a Lysine Deacylase with a Preference for Depropionylation and Demyristoylation. | Int J Mol Sci | 2025 | 40243935 | PubTator, text mining | PubMed |
| SIRT3/6/7: promising therapeutic targets for pulmonary fibrosis. | Front Cell Dev Biol | 2025 | 40241794 | PubTator, text mining | PubMed |
| Role of SIRT7 in Prostate Cancer Progression: New Insight Into Potential Therapeutic Target. | Cancer Med | 2025 | 40165597 | PubTator, text mining | PubMed |
| Correction: SIRT7 affects the proliferation and apoptosis of papillary thyroid cancer cells by desuccinylation of LATS1. | BMC Cancer | 2025 | 40165095 | PubTator, text mining | PubMed |
| Protocol for high-throughput screening of SIRT7 inhibitors using fluorescent peptide technology. | STAR Protoc | 2025 | 40156835 | PubTator, text mining | PubMed |
| SIRT7 facilitates endometrial cancer progression by regulating PTEN stability in an estrogen-dependent manner. | Nat Commun | 2025 | 40148340 | PubTator, text mining | PubMed |
| The Clinical Role of SIRT-3 in the Acute Rejection Process of Kidney Transplantation and Its Effects on Graft Outcomes: Evaluation of Biomarker Potential. | Medicina (Kaunas) | 2025 | 40142268 | PubTator, text mining | PubMed |
| SIRT7 affects the proliferation and apoptosis of papillary thyroid cancer cells by desuccinylation of LATS1. | BMC Cancer | 2025 | 40050771 | PubTator, text mining | PubMed |
| SIRT7 Expression Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma Undergoing Postoperative Platinum-Based Adjuvant Chemotherapy. | Urol Int | 2025 | 40015258 | PubTator, text mining | PubMed |
| Aprocitentan mitigates doxorubicin-induced cardiotoxicity by inhibiting cuproptosis, oxidative stress, and mitochondrial impairments via the activation of sirtuin 7. | Int Immunopharmacol | 2025 | 39930646 | PubTator, text mining | PubMed |
| Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapy. | Cell Rep | 2025 | 39908142 | PubTator, text mining | PubMed |
| Structural basis of SIRT7 nucleosome engagement and substrate specificity. | Nat Commun | 2025 | 39900593 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51547/papers?page=7